Immune Pharmaceuticals And STC Biologics Announce Strategic Partnership To Accelerate The Development of NanomAbs
May 04, 2015 at 07:32 AM EDT
Immune Pharmaceuticals Inc. (NASDAQ: IMNP), a clinical stage bio-pharmaceutical company with a first-in-class monoclonal antibody, ...